SAMD9L and systemic sclerosis: Recent studies have linked SAMD9L mutations to severe autoinflammatory syndromes, characterized by ILD, elevated inflammatory markers, cytopenias, and immune dysregulation, which closely resemble clinical and immunological features seen in SSc-ILD [70].